| Literature DB >> 36078782 |
Ryszard Maciejewski1, Elżbieta Radzikowska-Büchner2, Wojciech Flieger1, Kinga Kulczycka3, Jacek Baj1, Alicja Forma4, Jolanta Flieger5.
Abstract
Numerous factors affect reproduction, including stress, diet, obesity, the use of stimulants, or exposure to toxins, along with heavy elements (lead, silver, cadmium, uranium, vanadium, mercury, arsenic). Metals, like other xenotoxins, can cause infertility through, e.g., impairment of endocrine function and gametogenesis or excess production of reactive oxygen species (ROS). The advancement of nanotechnology has created another hazard to human safety through exposure to metals in the form of nanomaterials (NMs). Nanoparticles (NPs) exhibit a specific ability to penetrate cell membranes and biological barriers in the human body. These ultra-fine particles (<100 nm) can enter the human body through the respiratory tract, food, skin, injection, or implantation. Once absorbed, NPs are transported to various organs through the blood or lymph. Absorbed NPs, thanks to ultrahigh reactivity compared to bulk materials in microscale size, disrupt the homeostasis of the body as a result of interaction with biological molecules such as DNA, lipids, and proteins; interfering with the functioning of cells, organs, and physiological systems; and leading to severe pathological dysfunctions. Over the past decades, much research has been performed on the reproductive effects of essential trace elements. The research hypothesis that disturbances in the metabolism of trace elements are one of the many causes of infertility has been unquestionably confirmed. This review examines the complex reproductive risks for men regarding the exposure to potentially harmless xenobiotics based on a series of 298 articles over the past 30 years. The research was conducted using PubMed, Web of Science, and Scopus databases searching for papers devoted to in vivo and in vitro studies related to the influence of essential elements (iron, selenium, manganese, cobalt, zinc, copper, and molybdenum) and widely used metallic NPs on male reproduction potential.Entities:
Keywords: environmental factor; essential metals; male fertility; nanoparticles; public health; reproduction; toxicity
Mesh:
Substances:
Year: 2022 PMID: 36078782 PMCID: PMC9518444 DOI: 10.3390/ijerph191711066
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Causes of male infertility. This review is devoted to essential metals with potential toxicity and covers bulk materials and nanomaterials. Orange boxes show the connection of infertility with the subject of this review.
Concentrations of trace elements (mg L−1) in normal semen specimens or other biological materials taken from fertile men.
| Specimen | n | Ca | Mg | Zn | Se | Fe | Cu | Other | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| Blood | 96 | 48.7–52.0 | 73.7–76.6 | 6.76–7.10 | 0.230–0.246 | 449–469 | 0.89–1.00 | Pb, Cd, Hg | [ |
| Serum | 33.5–36.0 | 22.0–24.2 | 1.21–1.38 | 0.064–0.068 | 3.00–3.40 | 0.62–0.68 | |||
| SP | 59.0–62.3 | 71.7–75.4 | 138–152 | 0.034–0.035 | 269–283 | 148–165 | |||
| SP | 482 | - | - | 0.117 | 0.026 | 0.121 | 0.063 | 18 metals | [ |
| SP | 19 | 240.49 ± 50.5 | 60.85 ± 10.89 | 140.08 ± 20.01 | - | - | - | Na, K | [ |
| SP | 47 | - | - | 1.24–1.53 | - | - | - | - | [ |
| Semen | 22 | - | - | - | 0.054 ± 0.023 | - | - | Cd, Pb | [ |
| SP | - | - | - | 0.040 ± 0.016 | - | - | |||
| SP | 40 | - | 13.14 ± 3.65 | 141.7 ± 30.23 | 0.061 ± 0.018 | - | 165.56 ± 40.13 | - | [ |
| SP | - | - | - | 18–301 | 0.021–0.191 | 0.05–0.63 | 0.03–0.3 | Mn, I, Pb, Cd, Mo | [ |
| Semen | 97 | - | - | 7.626 ± 0.090 | - | - | - | - | [ |
| Serum 1 | 30 | 93.09 | 22.07 | 3.53 | 0.49 | 2.26 | 0.90 | Na, K | [ |
| SP 1 | 103.78 | 25.72 | 1.10 | 0.09 | 2.66 | 0.87 | |||
| SP | 28 | - | - | - | 0.07 ± 0.020 | - | 0.195 ± 0.045 | Mn, Pb, As | [ |
| SP | 96 | - | 550.12 ± 282.51 | 188.42 ± 99.61 | - | 2.02 ± 0.74 | 1.29 ± 0.58 | - | [ |
| SP | 64 | - | - | 0.127 ± 0.075 | 0.012 ± 0.019 | - | 0.041 ± 0.041 | As, Sb, Hg, Al, Cd, Ni, Pb, V Mn, Ti, Cr, Mo, | [ |
| SpermDNA | - | - | 0.018 ± 0.042 | - | - | 0.00011 ± 0.0003 | - | ||
| Blood | 30 | - | - | 0.213 ± 0.139 | - | - | 0.107 ± 0.084 | Pb, Cd | [ |
| SP | - | - | 0.131 ± 0.107 | - | - | 0.106 ± 0.094 |
1 Data obtained for bulls. SP—seminal plasma.
The role of Zn in male fertility and the effects of deficiency [76,77,80,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111].
| Organ or | Action | Zn Deficiency |
|---|---|---|
| HPG axis/ | Inhibition of 5α reductase and affinity to LH receptor | Low serum T, testicular failure, changed sex steroid hormone receptor levels, damaged LH receptors, increase in circulating LH, decrease in T synthesis in Leydig cells |
| Antioxidant defense system/ | Inhibition of DNases and activity of Cu/Zn SOD | Oxidative damages (lipids, proteins, DNA), increase in LPO, increased MDA in the serum and seminal plasma and reduced levels of SOD, damage to the Leydig cells, apoptosis |
| cell physiology/ | Inhibition of caspases, | DNA fragmentation, apoptosis, decreased population of the Leydig cells, germ cells, cell and tissue death |
| Epigenetics/ | Zn expression | Reduced reproductive potential, delayed sperm maturation |
| Testes/ | participation in spermatogenesis (mitosis of spermatogonia and spermatocyte meiosis) | Retarded genital development, reduced testes weight, changes in the structure of Leydig cells, lower sperm concentration of the ejaculate, hyperviscosity of semen |
| Spermatozoa physiology/ | lipid and protein metabolism, oxygen consumption, nucleic acid synthesis, epithelial membrane integrity, | Abnormal morphology, count, viability, motility of sperm, head–tail attachment problem, inhibition of spermatid differentiation, dysfunction of the zinc finger motif Cys2/His2 of P2 protamines |
| Fertilization/ | capacitation, | Change in pH, proteasomal activities, transfer of the amino peptidase from prostasomes, lower sperm membrane fluidity, improper fertilization |
Abbreviations: deoxyribonucleases (DNases).
Figure 2The effect of NPs on the fertility of in vivo and in vitro male models.
Influence of NPs on the male reproduction system. Based on Refs. [228,229,230].
| Model | Exposure | Cell Lines | Accumulation | Observations |
|---|---|---|---|---|
| In vitro | 0.05–1000 µg/mL/very short (<24 h), short (24–72 h), and long time (>96 h). | Germ cells: LCs, TM-3, PTCs, SCs, ISP-1, SSCs, SCs-GCs, CPCs, SPTs, C18-4 | Plasma membrane, head, midpiece, the tail of sperm, cytoplasm, cytoskeleton, nucleus, mitochondria | Damage to membrane integrity, potential, ion permeability, signal transduction; abnormal morphology (absent acrosome, head, disrupted chromatin heads, curved midpieces, tails), LPO, mitochondria (reduction in oxygen consumption and ATP levels); damage to mtDNA, the polymorphic profile of DNA; morphological changes (cell shrinkage, chromatin condensation, disorganization of microtubule network, necrosis); down-regulation of genes involved in cell proliferation, meiosis, and differentiation; induction of autophagy and apoptosis; reduced motility in spermatozoa, defects in acrosomal reaction, the ability to penetrate the oocyte, and blastocyst formation |
| Sertoli cells | Cytoplasm, nucleus | Loss of membrane integrity, membrane potential (dysfunction of BTB-related proteins), morphological changes (cellular and nuclear shrinkage, chromatin fragmentation, endoplasmic reticulum expansion, mitochondrial swelling, accumulation of autophagosomes, disordered microfilament networks), mitochondrial damage, DNA damage, decrease in cell viability, cell apoptosis | ||
| Leydig cells | Cytoplasm, | Steroidogenesis inhibition (testosterone production), | ||
| In vivo | (0.001 to 2000 mg/kg)/acute (1–14 days), subacute (repeated doses 14–28 days), subchronic (repeated | Testes | Brain, organs of the reproductive system (testes, epididymis, prostate, seminal vesicle, the seminiferous tubules, interstitial Leydig cells, Sertoli cells, spermatogonia, spermatocytes, spermatids, sperm cells), other organs (liver, spleen, kidneys, lungs) | Fertility rate decrease; testicular weight reduction; sperm quantity/quality (increase in sperm DNA damage, morphological abnormalities, motility, mitochondrial activity, and acrosome integrity); histopathological changes (intracellular vacuolations; degeneration, atrophy, and necrosis of germ cells, Sertoli cells, and Leydig cells; irregularities in plasma membrane; nuclear chromatin loss; mitochondria swelling and cristae disappearance; dilated endoplasmic reticulum; and increase in lysosomes), morphometric alterations of germinal epithelium; decline in the number of spermatogonia, spermatids, Sertoli and Leydig cells; impairments in spermatogenesis (reductions in germ cell content, reductions in daily sperm production and sperm count in testes and epididymis); changes in the expression of apoptosis-related proteins; changes in testosterone levels (plasma/serum, intratesticular testosterone) |
| HPG axis | Hormonal imbalance (GnRH, LH, FSH, prolactin, inhibin, DHT, estrogen, testosterone); changes of the transcript expression of genes involved in the regulation of the HPT axis (Gnrh, Esr1, Esr2, Ar, Inhbb) in hypothalamic, pituitary, and testicular tissues | |||
| epididymis | Histopathological changes (hyperplasia of epithelial cells, the lining of the duct of epididymis, cell pyknosis, necrosis and abscission, vacuolar cytoplasm in the cauda of principal cells, increased fibrotic tissues, infiltration of connective tissues and inflammatory cells, and interstitial congestion with ducts presenting empty lumen lacking spermatozoa) |
Abbreviations: gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), dihydrotestosterone (DHT); hypothalamus–pituitary–gonad axis (HPG axis); lipid peroxidation (LPO); mitochondrial DNA (mtDNA); blood–testes barrier (BTB).
The impacts of selected NPs on reproductive function in males.
| Model | Expose | Doses | Findings | Ref. |
|---|---|---|---|---|
|
| ||||
| Male albino mice BALB/c | Oral intake | 25, 35 mg/kg | Reduced proliferative activity and differentiation in the potential of epithelial cells; reduction in the number of Leydig cells, the incidence of necrosis, damage in organs (testes, epididymis, and seminal vesicles); spermatogenesis: low number of sperm, distorted sperm leading to the formation of embryos with some abnormalities; MDA and caspase-3 increased; Ki67 protein decreased; CD68 protein increased; reduction in the seminal vesicle, increased prostate size | [ |
|
| ||||
| New Zealand rabbit spermatozoa | Incubation | 6–391 mg/mL per 0, 1, 2, 3 h | Spermatozoa membrane integrity decrease, negative dose-dependent effect on spermatozoa motility and viability | [ |
| Male mice | Oral administration | 50, 150, 450 mg/kg for 14 days | Detachment, atrophy, and vacuolization of germ cells; vacuolization of Sertoli and Leydig cells; decrease in the number of sperm in the epididymis; decrease in the concentration of T in serum; up-regulated IRE1α, XBP1s, BIP, and CHOP genes; increase in the expression of caspase-3; reduced body weight; increased relative testicular weight and relative epididymis weight in a dose-dependent manner | [ |
| Adult albino rats | Oral subacute | 422 mg/kg/day for 4 weeks | Congestion in blood vessels; detached germinal epithelium from the basement membrane; absence of spermatozoa in seminiferous tubules; fragmentation of DNA in testicular and prostatic tissue; increase in the mean area percentage of iNOs immunoreactions; testicular and prostatic tissue inflammatory cytokines; elevation in serum level of MDA; reduction in GSH, CAT, and SOD activities | [ |
| Albino rats | Orally | 100 and 400 mg/kg/day for 12 weeks | Disorganization, vacuolation, and detachment of germ cells in testicular tissue; decrease in sperm cell count, sperm motility, live percentage of sperm and normal sperm; decrease in serum testosterone level and antioxidant enzymes activity (SOD and CAT) and the GSH-Px level; increase in LPO in the affected testes; decrease in 3β-HSD, 17β-HSD, and Nr5A1 transcripts; quercetin—beneficial for preventing or ameliorating ZnO-NP reproductive toxicities | [ |
| Male NMRI mice | Orally | 5, 50, 300 | Spermatogenetic factors: change in the number and motility of sperm, decrease in the diameter and height of the seminiferous tubules, blocking of the maturity of sperm cell lines, epithelial vacuolization, increase in sloughing of germ cells and their detachment, formation of multinucleated giant cells in germinal epithelium | [ |
| Semen from healthy persons | Incubation | 10–1000 µg/mL | Dose- and time-dependent cytotoxicity; | [ |
| Sertoli (TM-4) and spermatocyte (GC2-spd) cell lines (in vitro models) | - | 8 μg/mL | Induced oxidative stress in both cells lines (decreased glutathione level and increased MDA level) | [ |
| Male rats | Intraperitoneal i.p. injected | 5 mg/kg once a week for 8 weeks | Group treated with Cis and ZnO-NPs: decrease in ROS BTB proteins restoration, enhanced architecture of the testes, and increased sperm DNA integrity | [ |
|
| ||||
| Male Sprague Dawley rats | Orally | 5, 15, 45 mg/kg/day for 10 weeks | Increased FSH and LH, lowered estradiol (E2), serum levels | [ |
| BALB/c mice (in vivo),GC-1 cells(in vitro) | Orally/incubation | 5, 15, and 45 mg/kg/day | In vivo: serum T, FSH, LH, and sperm count decreased; sperm abnormality; expression of Drp1, Pink1, and Parkin proteins increased; seminiferous tubules of the testes changed | [ |
| BALB/c mice | Intratracheal instillation | 0.1 mL/10 g once a week for 28 days | Changes in sperm deformity and serum reproductive hormones, apoptotic cells number increased; testicular spermatogenic cells damage; expressions of proteins (Drp1, Pink1, Parkin) increased | [ |
|
| ||||
| Wistar rats | Oral exposure | 15 and 50 µg/kg BW | Weight not changed, growth less diminished, sperm reserves in the epididymis and diminished sperm transit time, a reduction in sperm production, impairment in spermatogenesis, and lower sperm count | [ |
| Wistar rats | Intravenous administration | 5 and 10 mg/kg BW | Decrease in epididymal sperm count; increased level of DNA damage in germ cells; change in the testes’ seminiferous tubules morphometry, adipose tissue distribution, and the frequency of abnormal spermatozoa; no alteration in body and organ weight, 20 nm AgNP—more toxic than 200 nm ones | [ |
| Male rats | Sub-dermal | 50 mg/kg BW for 28 or 7 days | Reduction in BW, decrease in the relative weight of the testes and epididymis with the same dose exposure for 7 days, Ag-NP triggered hormonal imbalance and induced oxidative stress in the testes and epididymis, negatively affecting sperm parameters | [ |
| Wistar albino rats | Intraperitoneal injection | 100 mg/kg/day for 7 days 1000 mg/kg/day for 7 or 28 days | Congestion of blood vessels, detachment of the germinal epithelium and distortion in seminiferous tubules, reduction in the germinal epithelium, absence of spermatozoa in shrunk seminiferous tubules, tissue damage increased with increased dose and duration of exposure | [ |
| Male rats | Intraperitoneally injected | 2 or 4 mg/kg BW | Damaging changes of the seminiferous tubules, vacuolation in the seminiferous tubules with a reduced number of spermatogenic cell lines (at a low NPs dose), | [ |
| Male mice | Intraperitoneally injection | 0.2 mL once a week at a dose of 40 mg/kg of BW | Sexual behavior, oxidative defense parameters, sperm count, and motility of the sperm, the apoptotic cells in testicular cross-sections, and TBARS level increased; | [ |
| Spermatozoa (BDF1) mice | Addition | 0.1, 1, 10, or 50 μg/mL incubated at 37 °C for 3 h | Sperm viability and the acrosome reaction inhibition in a dose-dependent manner, increased sperm mitochondrial copy numbers, morphological abnormalities, mortality decreased, decrease in the rate of oocyte fertilization and blastocyst formation, lower expression of trophectoderm-associated and pluripotent marker genes in blastocysts | [ |
|
| ||||
| Male mice | Intraperitoneal exposure | 25 and 50 mg/kg once a week for 4 weeks | Sloughing and detachment of germ cells and vacuolization in seminiferous tubules of the testicular tissues; accumulation of NPs; increased ROS species, LPO, protein carbonyl content, GPx activity, and NO levels; decrease in SOD, CAT, glutathione, and vitamin C levels; increased serum T levels, expression of Bax, cleaved-caspase-3, and cleaved-PARP; cell apoptosis; damage to the seminiferous tubules; decrease in the number of spermatogonia, primary spermatocytes, spermatids | [ |
|
| ||||
| Male albino rats | Intraperitoneal injection | 300 mg/kg for 14 days | Increases in the thickness of interstitial space, congestion of blood vessels, and detachment of the germinal epithelium from the basement membrane in the seminiferous tubules, beneficial effects of beta carotene administration | [ |
| Sertoli cell culture | Incubation | 5, 15, or 30 lg/mL for 24 h | Reduction in cell viability, lactate dehydrogenase release, and induction of apoptosis or death of Sertoli cells; | [ |
|
| ||||
| Male rats | Oral | 70 mg/kg BW | Distortion in seminiferous tubules; wide spaces among interstitial cells (Al2O3-NPs); irregularity in the seminiferous tubules’ shape, empty lumina; and reduced thickness of the epithelium lining (ZnO-NPs; 100 mg/kg BW); co-administration of Al2O3-NPs, ZnO-NPs caused severe damage to the seminiferous tubules and basement membrane | [ |
|
| ||||
| Male mice BABL/c (in vivo), TM3 cells (in vitro) | Intravenously injected | 0.17 or 0.50 mg/kg/day 0 for 14 days | Accumulation of NPs in the testes; reduced plasma T; increased rate of epididymal sperm malformation; induced autophagosome formation; enhanced ROS production; disrupted cell cycle, DNA damage, and cytotoxicity in TM3 Leydig cells; inhibition of the synthesis of T in TM3 cells; reduced expression of 17α-hydroxylase | [ |
| Male bulb-c mice | Intraperitoneal injection | 40 and 200 µg/kg/day for 7 and 35 days | Sperm motility and morphology decrease, | [ |
| TM-4 Sertoli cells | Addition of gold nanorods | 0 and 10 nM for 24 h | Decreased glycine synthesis, membrane permeability, mitochondrial membrane potential, and disruption of BTB factors in TM-4 Sertoli cells; aberrant expression of imprinted genes in TM-4 Sertoli cells. | [ |
|
| ||||
| Holstein bull semen | Incubation | 10−6–10−2 M | Plasma membrane integrity improved in the semen, | [ |
|
| ||||
| Albino Wistar rats | Sub-chronic injection | 100 mg/kg/day for 4 weeks | Decrease in the number of sperm, spermatogonia, spermatocytes, the diameter of seminiferous tubules, motility of the sperm; | [ |
|
| ||||
| Taihang black goats | Oral | 0.3 mg/kg | Increase in final BW, total blood, serum and tissue Se concentration, serum GSH-Px, SOD, CAT, MDA | [ |
| Male Boer goats | Oral | 0.3 mg/kg for 12 weeks | Testicular Se level, semen GPx, and ATPase activity increased; semen volume, density, motility, and pH—not affected; membrane system integrity improved; positive effects of nano-Se diet supplementation on sperm abnormality, abnormal spermatozoal mitochondria, membrane system integrity | [ |
|
| ||||
| The ejaculates of Sarda rams | Incubation | 0.44 and 220 μg/mL | A beneficial effect on motility parameters, the velocity of sperm cells enhanced, beneficial effects on the integrity of plasma membranes of spermatozoa, no change in production of ROS after 96 h of incubation—at 4 °C, the integrity of DNA was constant | [ |
Abbreviations: body weight (BW); relative weight (RW); glutathione peroxidase (GSH-Px); superoxide dismutase (SOD); catalase (CAT); malondialdehyde (MDA); aniline blue (AB); toluidine blue (TB); chromomycin A3 (CMA3); blood–testes barrier (BTB); cisplatin (Cis); reactive oxygen species (ROS); follicle-stimulating hormone (FSH); luteinizing hormone (LH); testosterone (T); lipid peroxidation (LPO); thiobarbituric acid reactive substances (TBARS); endoplasmic reticulum stress (ER stress); yttrium oxide nanoparticles (YO-NPs); mitochondrial membrane potential (MMP); adenozyno-5′-trifosforan (ATP); mitochondrial membrane potential (DWm).